The latest headlines across every section, pulled from official and open-access sources.
If hospitals are going to stay ahead, revenue cycle leaders must shift from reaction to strategy. Here are some key areas of focus. The post When AI Becomes a Payer Advantage, Hospitals Cannot Afford to Stay Reactive appeared first on MedCity News .
Objectives To determine the prevalence, patterns and correlates of medicinal herb use in a rural Iranian population and to evaluate demographic and clinical predictors using adjusted regression models. Design Cross-sectional analysis of baseline data from the Fasa Prospective Epidemiological Research Studies in Iran Cohort Study. Setting Sheshdeh, a rural district in southern Iran. Participants 10 143 adults aged 35–70 years enrolled between 2017 and 2019. Primary outcome measures Prevalence of self-reported medicinal herb use during the past year and its associations with demographic…
Introduction In kidney transplantation, immunosuppressive therapy is essential to control alloimmune reactions, prevent graft rejection and improve patient survival rates. However, commonly used drugs like tacrolimus (TAC) and mycophenolate mofetil (MMF) have a narrow therapeutic window and exhibit significant inter- and intra-individual variability in pharmacokinetics (PK) and dose-response relationships. Recent pilot studies suggest that the gut microbiome may influence this variability. Methods and analysis ElucidatiNg Immunosuppressant pharmacokinetic variabilities by investigating Gut…
Introduction A proportion of patients hospitalised for COVID-19 acquire the disease during their hospital stay, underscoring the risk of hospital-acquired COVID-19 (HA-COVID-19). This risk is presumed to be high, given how commonly and intensely air and surfaces within hospitals are reportedly contaminated with SARS-CoV-2. However, the true extent of HA-COVID-19 worldwide remains unknown, with limited understanding of factors that influence its occurrence and how these have evolved over time. This review will therefore aim to estimate the pooled prevalence of HA-COVID-19 among hospitalised…
Introduction Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) is a promising respiratory support method for avoiding invasive mechanical ventilation in neonatal intensive care units (NICUs). However, its effectiveness and safety have not been widely established through clinical evidence. In this study, we aim to evaluate the feasibility of NIV-NAVA as a primary respiratory support method after birth and its effects on short-term clinical outcomes and long-term neurodevelopment in preterm infants. Methods and analysis In this prospective multicentre observational study, 230 preterm…
Objectives This study aimed to analyse temporal trends in fertility and birth rates, examine maternal characteristics and forecast future demographic changes in Georgia. Design This was a retrospective observational study using population-level data from the National Statistics Office of Georgia (Geostat) and the Georgian Birth Registry (GBR). Temporal trends were analysed using Prais-Winsten regression models and annual percentage changes (APCs) and future projections were generated using autoregressive integrated moving average (ARIMA) models. Participants The study included data on 543 662…
Introduction Poststroke depression (PSD) affects approximately 33% of stroke survivors and is associated with worse outcomes, poor quality of life (QOL) and mortality. Despite its prevalence and consequences, there is no consensus on the most effective strategy for PSD prevention. Behavioural activation (BA) is an effective intervention for depression across diverse populations and is considered safer, better tolerated and a longer-lasting alternative to antidepressant medications. This study aims to test the effectiveness of a remotely delivered BA intervention to prevent PSD (Tele-BA-S)…
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health mcarmody Sun, 06/07/2026 - 06:28 Press release Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health NEW ORLEANS, La. June 7, 2026 Injectable Offers Potential to Reduce Fatty Liver Diseases and Improve Health Markers in Adults New data highlight the potential benefits of survodutide, a once-weekly injectable therapy targeting both the glucagon and glucagon-like peptide-1 (GLP-1) receptors in individuals with obesity and metabolic dysfunction-associated…
The American Diabetes Association Announces Winners of the Innovation Challenge mcarmody Sat, 06/06/2026 - 18:52 Press release The American Diabetes Association Announces Winners of the Innovation Challenge NEW ORLEANS, La. June 6, 2026 Today, from the main stage at the organization’s 2026 Scientific Sessions, the American Diabetes Association ® (ADA) announced the winners of the 2026 Innovation Challenge competition. Each year, the Innovation Challenge seeks game-changing ideas from emerging companies that have the potential to transform diabetes care. “There is tremendous…
KFF Health News' editor-at-large for public health discussed Ebola, GLP-1 drugs, ultraprocessed food, and more in TV appearances this week.
Update on Ebola Outbreak in the Democratic Republic of the Congo and Uganda, 6/5/2026
CDC warns of Listeria outbreak linked to requesón/soft ricotta cheese
CereVasc is developing a minimally invasive treatment for the buildup of fluid in the brain.
Winona launched a new research initiative to fund and support menopause and women’s health research. The post Winona Launches Menopause Research Initiative appeared first on MedCity News .
Contraline raised $92.5 million in new funding to advance its two male contraceptive candidates, including a once-daily topical gel and an implantable option. The post Contraline Secures $92.5M to Push Its Male Birth Control Candidates Forward appeared first on MedCity News .
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Nelson & Isa Lacteos LLC. of Bayshore, NY, is recalling 1lb packages of Requeson Cheese because they may be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems
The MHRA register of licensed manufacturing sites: manufacturer specials - human (MS) and manufacturer specials authorisation - veterinary (MANSA) only.
Current listing of UK brokers authorised to broker human medicines, including company name, registration and address.
List of sites granted a manufacturer or wholesale dealer licence.
UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.
Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human).
Source: National Institute of Mental Health - Related MedlinePlus Pages: Personality Disorders
Avacopan is used in the treatment of some rare autoimmune diseases affecting small blood vessels.